AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $32,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,873 | $26,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 95,754 | $206,000 | 0.03% |
| Arkadios Wealth Advisors | 20,000 | $45,400,000 | 0.02% |
| Bayesian Capital Management, LP | 42,200 | $91,000 | 0.02% |
| SeaCrest Wealth Management, LLC | 50,515 | $109,000 | 0.02% |
| Virtu Financial LLC | 29,604 | $64,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $31,000 | 0.01% |
| WEDBUSH SECURITIES INC | 13,295 | $29,000 | 0.00% |
| Verition Fund Management LLC | 40,000 | $86,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11,600 | $25,000 | 0.00% |